However, because the impact of other functional roles and different subsets of DCs during CDI is unknown, the use of more specific tools to target DCs, such as DTR-transgenic mouse lines targeting Xcr1, Clec9a, and Zbtb46 during CDI, is warranted (71, –, 75). The gene discussed is CLEC9A; the disease is clostridium difficile infection.